<?xml version="1.0" encoding="UTF-8"?>
<p>The available JEV data are predominantly derived from hospital-based studies and are therefore likely to underestimate community incidence as most JEV infections are asymptomatic and only an estimated 1 in 250–500 infections result in clinical signs 
 <xref rid="pntd.0002533-Barboza1" ref-type="bibr">[16]</xref>, 
 <xref rid="pntd.0002533-Japanese1" ref-type="bibr">[17]</xref>. Those signs vary greatly, ranging from a flu-like or dengue-like febrile syndrome—which is frequent in children in the Mekong region—to severe encephalitis, with a case-fatality rate (CFR) estimated at 5–40% (up to 60% for severe forms). Neurological sequelae occur in 30–50% of survivors and are often severe 
 <xref rid="pntd.0002533-Srey1" ref-type="bibr">[18]</xref>–
 <xref rid="pntd.0002533-Touch2" ref-type="bibr">[22]</xref>, although it seems that a majority of patients recovered after three to five years in one large study in India 
 <xref rid="pntd.0002533-Sarkari1" ref-type="bibr">[23]</xref>. It has been estimated 
 <xref rid="pntd.0002533-Labeaud1" ref-type="bibr">[24]</xref> that 265,778–1,859,170 disease-adjusted life years (DALYs) were lost to JEV worldwide in 2005.
</p>
